MARTINELLI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 4.029
AS - Asia 3.579
EU - Europa 3.458
SA - Sud America 457
Continente sconosciuto - Info sul continente non disponibili 130
AF - Africa 80
OC - Oceania 6
AN - Antartide 1
Totale 11.740
Nazione #
US - Stati Uniti d'America 3.888
SG - Singapore 1.703
RU - Federazione Russa 1.095
IT - Italia 944
VN - Vietnam 699
CN - Cina 537
UA - Ucraina 433
BR - Brasile 362
HK - Hong Kong 335
DE - Germania 235
FR - Francia 173
NL - Olanda 132
FI - Finlandia 119
GB - Regno Unito 98
SE - Svezia 95
CA - Canada 82
IN - India 43
JP - Giappone 42
BD - Bangladesh 38
IE - Irlanda 37
AR - Argentina 34
MX - Messico 29
PL - Polonia 25
ZA - Sudafrica 25
IQ - Iraq 19
CI - Costa d'Avorio 18
PH - Filippine 18
TH - Thailandia 18
EC - Ecuador 17
KR - Corea 17
AT - Austria 16
TR - Turchia 16
ES - Italia 15
ID - Indonesia 15
PK - Pakistan 11
EG - Egitto 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
CO - Colombia 8
MA - Marocco 8
TW - Taiwan 8
VE - Venezuela 8
PY - Paraguay 7
JO - Giordania 6
PE - Perù 6
UY - Uruguay 6
UZ - Uzbekistan 6
BS - Bahamas 5
CL - Cile 5
IL - Israele 5
KZ - Kazakistan 5
NP - Nepal 5
AM - Armenia 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
JM - Giamaica 4
AZ - Azerbaigian 3
BE - Belgio 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
HR - Croazia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AU - Australia 2
BB - Barbados 2
GT - Guatemala 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
ML - Mali 2
MN - Mongolia 2
MY - Malesia 2
NR - Nauru 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
AQ - Antartide 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
Totale 11.596
Città #
San Jose 749
Singapore 725
Chandler 392
Hong Kong 319
Moscow 317
Jacksonville 316
Ashburn 239
Ho Chi Minh City 205
Hanoi 154
Beijing 152
Los Angeles 117
Millbury 108
The Dalles 108
Santa Clara 101
Princeton 99
Amsterdam 94
Lauterbourg 92
Napoli 74
Boston 71
Naples 64
Buffalo 62
Wilmington 53
Nanjing 47
Council Bluffs 40
Kronberg 40
Milan 38
Ottawa 37
Houston 36
New York 36
Tokyo 33
Munich 30
Dallas 29
Rome 29
São Paulo 29
Da Nang 28
Hefei 27
Orem 27
Seattle 27
Palermo 25
Nanchang 23
Denver 22
Frankfurt am Main 21
Helsinki 19
Haiphong 18
Norwalk 18
Atlanta 16
Dalmine 16
Des Moines 16
Montreal 16
Orange 16
Warsaw 16
Brooklyn 15
Hebei 15
Chennai 14
Redondo Beach 14
Changsha 13
Johannesburg 13
Mexico City 13
Poplar 13
Tianjin 13
Bari 12
Dong Ket 12
Hải Dương 12
Toronto 12
Boardman 11
Chicago 11
Rio de Janeiro 11
Biên Hòa 10
Falkenstein 10
Luzzano 10
Manchester 10
Nuremberg 10
Shenyang 10
Verona 10
Vienna 10
Genoa 9
London 9
Stockholm 9
Brasília 8
Bắc Giang 8
Pune 8
Belo Horizonte 7
Bologna 7
Bắc Ninh 7
Chieti 7
Guayaquil 7
Lawrence 7
Ninh Bình 7
Paris 7
Phoenix 7
Redwood City 7
Salvador 7
Thái Nguyên 7
Washington 7
Amman 6
Bangkok 6
Dhaka 6
Florence 6
Salerno 6
San Francisco 6
Totale 5.848
Nome #
Leucemia acuta a cellule hand mirror con immunofenotipo ibrido: un caso clinico. 453
Deformazione di globuli rossi in flusso in microcapillari 234
Secondary syphilis mimicking malignancy: A case report and review of literature 216
Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation 183
Clinical, Immunological, and Functional Characterization of Six Patients with Very High IgM Levels 179
Transition index: new original tool to identify subsets overlapping MPN phenotypes. 178
A Novel Score to Predict Interferon-Alpha Therapy Responsiveness in Patients with Essential Thrombocythemia 169
EPIDEMIOLOGICAL, DIAGNOSTIC, THERAPEUTIC AND PROGNOSTIC ASPECTS OF ESSENTIAL THROMBOCYTHEMIA IN RETROSPECTIVE STUDY OF THE GIMMC GROUP IN TWO THOUSAND PATIENTS 158
HLA class I regulation of a T-cell leukemia proliferation 157
La ciclosporina nella terapia della neutropenia "autoimmune" in una paziente con sindrome connettivitica. 157
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 156
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 155
SPLEEN VOLUME IS THE MOST ACCURATE PARAMETER TO AVOID UNDERSTIMATION OF 25% SPLENOMEGALIC PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA 149
CONTAGLOBULI AUTOMATICI E CORREZIONE DEL VALORE DI EMOGLOBINA IN PAZIENTI CON IPERLEUCOCITOSI 148
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 146
A methodology to study the deformability of red blood cells flowing in microcapillaries in vitro 142
UVB phototherapy for pruritus in polycythaemia vera 141
Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. 141
SPLEEN VOLUME ASSESSMENT IN HEMATOLOGIC DISEASES: CT VERSUS US 139
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 139
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib 135
Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: A real-life experience 134
L'uso delle sonde molecolari nella diagnostica delle malattie linfoproliferative e della leucemia mieloide cronica DNA probes for lymphoproliferative disorders and Chronic Myeloid Leukemia 133
Anagrelide in Essential Thrombocythemia: a retrospettive study” 133
Incidence of thyroiditis in Essential Thrombocythemia patients treated by a-IFN 127
JAK2 MUTATION IN PHILADELPHIA NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS: PRELIMINARY DATA FROM A SINGLE CENTRE 127
Deformability of red blood cells in microchannels 123
Spectroscopical and Mechanical Characterization of Normal and Thalassemic Red Blood Cells by Raman Tweezers 121
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. 120
11 CASI DI PSEUDOTROMBOCITOPENIA 119
Peg-Interferon a-2b in Essential Thrombocythaemia: phase II study for determination of the minimum effective, safe and tolerated dose, preliminary data 115
Spleen sizing in essential thrombocythemia 115
SAVING MONEY AND COMFORT BY GAINING CYTOSINE ARABINOSIDE MICROGRAMS 115
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis 115
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. 113
Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study 110
Interferon alfa treatment for pregnant women affected by essential thrombocythemia: case reports and a review. 109
LOCALIZATION OF THE BREAKPOINT IN THE M-BCR IN 31 CASES OF CML. PRELIMINARY OBSERVATIONS. 108
80 CASI DI PSEUDOTROMBOCITOPENIA. 108
I geni Vk nella malattia di Waldestrom presentano mutazioni somatiche. 108
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 108
GATA-1: A potential novel biomarker for the differentiation of essential thrombocythemia and myelofibrosis 108
Severe Reactivation of Hepatitis B Virus Infection in a Patient with Hairy Cell Leukemia: Should Lamivudine Prophylaxis be Recommended to HBsAg-Negative, Anti-HBc-Positive Patients? 107
Localizzazione al nervo ottico in due casi di leucemia linfoblastica acuta con fenotipo T 107
Residual disease detected by DNA analysis is predective of early relapse. 107
Splenectomy in idiopathic thrombocytopenic purpura: follow-up in 53 cases 107
ADIA e linfoma 105
Optic nerve involvement in acute lymphoblastic leukemia. 105
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: Identification of a novel cluster 104
Caratterizzazione molecolare delle leucemie 104
Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 103
LOW DOSE PEG INTERFERON A2B (PEG INTRON) IN ESSENTIAL THROMBOCYTHAEMIA 103
Hypercitosis and spleen volume 100
Caratteristiche molecolari inusuali in un caso di leucemia acuta linfoblastica 99
SPLEEN ENLARGMENT FOLLOWING RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ADMINISTRATION FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION 99
Interferon to treat Essenzial Thrombocythemia during pregnancy: 4 cases and a letterature review 98
L'entità dell'emolisi acida nella EPN in relazione alla forza ionica del mezzo 97
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. 96
Lymphnode localization of extramedullary myeloid cell tumor in myelodysplastic syndrome: report of one case diagnosed by fine-needle cytology. 95
Spleen enlargement following recombinant human granulocyte colony-stimulating factor administration for peripheral blood stem cell mobilization 95
High number of circulating CD34+ cells in patients with myelophthisis 93
L'analisi molecolare del DNA nelle leucemie con metodica non radioattiva 92
Complete phenotipic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia 92
Red blood cell deformability in microconfined shear flow 92
Long survival in two cases of acute myelogenous leukemia complicated by chronic active hepatitis 91
Peg Interferon a- 2b (Peg Intron) in essential Thrombocythemia 90
Low dose of G- CSF and Cy-A in a case of severe neutropenia associated with clonal T-cell population 90
Ramipril in post-renal transplant erythrocytosis. 90
FATTORI AMBIENTALI E MALATTIE EMATOLOGICHE 89
A new pyrimidine 5’ nucleotidase variant? 89
Differential Regulatory Role of Monomorphic and Polymorphic Determinants of Histocompatibility Leukocyte Antigen Class-i Antigens In Monoclonal-antibody Okt3-induced T-cell Proliferation 89
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™—the FUTURE study 88
Three good reasons for using Interferon in essential thrombocythemia: off-therapy achievement, complete remission maintained by low doses and unmodified bone marrow fibrosis 87
Thirteen case of pseudothrombocitopenia 87
LONG SURVIVAL IN TWO CASES OF LEUKEMIA COMPLICATED BY CHRONIC ACTIVE HEPATITIS 85
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. 84
ATTIVITÀ IN VITRO DELL'ALPHA-INTERFERON E DEI PUVA SUI PROGENITORI ERITROIDI CIRCOLANTI DEI POLICITEMICI 83
LA TERAPIA CONVENZIONALE DELLE SINDROMI MIELODISPLASTICHE 82
Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients? 82
Measurement of spleen volume by ultrasound scanning in patient with thrombocytosis: a prospective study 81
Interleuchina 2 ed interleuchina 1 sono fattori di regolazione autocrina nelle leucemie acute linfoblastiche e nelle leucemie linfatiche croniche 81
Bone marrow biopsy and aspirate evaluation in 90 patients with Essential Thrombocythemia treated with PEG Interferon alpha-2b. Preliminary results 77
INTERLEUCHINA I AGISCE COME FATTORE AUTOCRINO DI PROLIFERAZIONE DI CELLULE B UMANE 77
Proliferative Pathways In Cd1- Cd3+ Cd4+ Cd8+ T-prolymphocytic Leukemic-cells - Analysis With Monoclonal-antibodies and Cytokines 77
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program 76
RAMIPRIL IN POST-RENAL TRANSPLANT ERYTHROCYTOSIS 75
RUOLO DELLE CITOCHINE NELL' INFEZIONE DA HTLV III 75
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy. 75
Optic nerve involvement in acute lymphoblastic leukemia 74
High number of circulating CD34+ cells in patients with myelophthisis. 74
Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. 74
NEUTROPENIA ASSOCIATED WITH LARGE GRANULAR LYMPHOCYTE PROLIFERATION: STUDY OF THREE CASES 72
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 71
UVB phototherapy for pruritus in polycythemia vera. 69
Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation 69
Late appearance of t(8;14) with c-myc rearrangement and disappearance of JH rearrangement leading to aggressive progression in a case of low grade non Hodgkin’s lymphoma” 69
Measurement of spleen volume by ultrasound scanning in patients with thrombocytosis: a prospective study. 67
Long term survival in acute myelogenous leukemia complicated by chronic active hepatitis 67
Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera 67
Delezione interstiziale del 9q in un caso di AML 67
Totale 11.184
Categoria #
all - tutte 37.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022587 0 16 12 10 5 17 20 18 55 47 146 241
2022/2023867 130 93 37 87 84 96 4 76 109 97 43 11
2023/2024513 23 76 57 34 32 38 24 85 2 11 90 41
2024/20252.661 174 137 22 44 83 123 297 152 260 322 840 207
2025/20265.052 565 325 486 440 813 176 815 271 604 377 71 109
2026/2027161 127 34 0 0 0 0 0 0 0 0 0 0
Totale 11.740